Clinical Trial Update: Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males [Phase 2]

View source ↗

Summary

Phase 2 trial assessing intradermal avotermin (Juvista) for anti-scarring efficacy and safety in healthy male participants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatrix
• Scar

Drugs mentioned

• Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix | Phase 2 | Status: COMPLETED